|
Volumn 22, Issue 5, 2002, Pages 194-198
|
Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy
a a a a a a a |
Author keywords
Calcitonin; Calcium; Cytokines; Osteocalcin; Postmenopausal osteoporosis
|
Indexed keywords
CALCITONIN;
CALCIUM ANTAGONIST;
CYTOKINE;
INTERLEUKIN 10;
INTERLEUKIN 1BETA;
INTERLEUKIN 2;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 6;
INTERLEUKIN 6 RECEPTOR;
INTERLEUKIN 8;
OSTEOCALCIN;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
ARTICLE;
BONE TURNOVER;
CALCITONIN BLOOD LEVEL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SCREENING;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
PATHOGENESIS;
POSTMENOPAUSE;
POSTMENOPAUSE OSTEOPOROSIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
STATISTICAL SIGNIFICANCE;
AGED;
ANALYSIS OF VARIANCE;
BIOLOGICAL MARKERS;
BONE DENSITY;
CALCITONIN;
CALCIUM COMPOUNDS;
CASE-CONTROL STUDIES;
CYTOKINES;
DENSITOMETRY, X-RAY;
HUMANS;
INJECTIONS, INTRAMUSCULAR;
INTERLEUKINS;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
PROBABILITY;
PROSPECTIVE STUDIES;
REFERENCE VALUES;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0036041033
PISSN: 01728172
EISSN: None
Source Type: Journal
DOI: 10.1007/s00296-002-0223-x Document Type: Article |
Times cited : (41)
|
References (34)
|